Aprepitant for gefitinib-induced refractory pruritus in Chinese malignancy population

DOI: 10.21037/atm.2019.01.02

Keywords: Aprepitant, rash, pruritus, gefitinib, non-small cell lung cancer (NSCLC)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text